Recursion Pharmaceuticals Inc (RXRX)

Apr 05, 2026

Recursion names Vicki Goodman as CMO - MSN

Apr 05, 2026

Apr 05, 2026

Fund Flows: Is Recursion Pharmaceuticals Inc forming a double bottom2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Recursion Pharmaceuticals, Inc. (RXRX) latest stock news and headlines - au.finance.yahoo.com

Apr 04, 2026

Apr 04, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 04, 2026

Recursion Pharmaceuticals, Inc. (RXRX) stock price, news, quote and history - Yahoo Finance Singapore

Apr 04, 2026

Apr 03, 2026

Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)? - Sahm

Apr 03, 2026

Apr 02, 2026

Recursion Pharmaceuticals (RXRX) beats stock market upswing: What investors need to know - MSN

Apr 02, 2026

Apr 02, 2026

Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

Director at Recursion (NASDAQ: RXRX) awarded 3,268 shares - Stock Titan

Apr 02, 2026

Apr 02, 2026

RXRX|Recursion Pharmaceuticals Inc|Price:3.110|Chg%:0.05 - TradingKey

Apr 02, 2026

Apr 02, 2026

A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge - Sahm

Apr 02, 2026

Apr 01, 2026

1 Beaten-Down AI Stock to Buy and 1 to Avoid - Yahoo Finance

Apr 01, 2026

Mar 31, 2026

Citeline expands partnership with Recursion for clinical trials - investing.com

Mar 31, 2026

Mar 31, 2026

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - GlobeNewswire Inc.

Mar 31, 2026

Mar 31, 2026

2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

RXRX Stock Price, Quote & Chart | RECURSION PHARMACEUTICALS-A (NASDAQ:RXRX) - ChartMill

Mar 31, 2026

Mar 30, 2026

Recursion Pharmaceuticals (RXRX) down 16.5% since last earnings report: Can it rebound? - MSN

Mar 30, 2026

Mar 29, 2026

RXRX SEC FilingsRecursion Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 29, 2026

Mar 29, 2026

Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - MSN

Mar 29, 2026

Mar 28, 2026

Recursion Pharmaceuticals (NASDAQ:RXRX) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Mar 28, 2026

Mar 27, 2026

Recursion Pharmaceuticals stock hits 52-week low at $2.98 By Investing.com - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals | SCHEDULE 13G/A: Others - Moomoo

Mar 27, 2026

Mar 27, 2026

RXRX Faces Stock Strain as Bank of America Slashes Price Target - StocksToTrade

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals (NASDAQ:RXRX) Reaches New 52-Week LowWhat's Next? - MarketBeat

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals (RXRX) Has Fallen 16.5% Since Previous Earnings Report: Is a Recovery Possible? - Bitget

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals stock hits 52-week low at $2.98 - Investing.com

Mar 27, 2026

Mar 27, 2026

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Mar 27, 2026

Mar 26, 2026

RXRX Stock: Why Did Nvidia Offload AI Drug Developer Recursion? - cmcmarkets.com

Mar 26, 2026

Mar 26, 2026

New Recursion CMO Puts Oncology Experience At Center Of Investor Focus - Sahm

Mar 26, 2026

Mar 26, 2026

Assessing Recursion Pharmaceuticals (RXRX) Valuation After Recent Share Price Weakness And Split Fair Value Views - Yahoo Finance

Mar 26, 2026

Mar 26, 2026

Recursion Pharmaceuticals Appoints Vicki Goodman, M.D. as Chief Medical Officer to Advance Clinical Pipeline and AI-Driven Drug Development 1 - Minichart

Mar 26, 2026

Mar 25, 2026

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gibson Christopher - Moomoo

Mar 25, 2026

Mar 25, 2026

Recursion Pharmaceuticals Names New Chief Medical Officer - TipRanks

Mar 25, 2026

Mar 25, 2026

Recursion appoints Vicki Goodman as Chief Medical Officer; David Mauro to transition to advisor - tradingview.com

Mar 25, 2026

Mar 25, 2026

Vicki Goodman to become Recursion (NASDAQ: RXRX) chief medical officer - Stock Titan

Mar 25, 2026

Mar 25, 2026

[Form 4] RECURSION PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Mar 25, 2026

Mar 25, 2026

Recursion Pharmaceuticals (RXRX) Goldman Sachs 45th Annual Global Healthcare Conference summary - Quartr

Mar 25, 2026

Mar 25, 2026

EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM - GuruFocus

Mar 25, 2026

Mar 25, 2026

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer - marketscreener.com

Mar 25, 2026

Mar 25, 2026

Recursion taps former FDA reviewer Vicki Goodman as chief medical officer - Stock Titan

Mar 25, 2026

Mar 24, 2026

Assessing Recursion Pharmaceuticals (RXRX) Valuation After Prolonged Share Price Weakness - Sahm

Mar 24, 2026